F644 in Pennsylvania. Pick another state for the same tag.
Against expectation — 2025
Pennsylvania cites F644 less often than its own record predicts
Versus expected share0.19×
0.19 times the national share — cited less often here than elsewhere.
Share of Pennsylvania citations0.12%
Of every deficiency written in Pennsylvania in 2025, this is the portion that was F644.
Pennsylvania0.12%
National0.64%
Share of all citations that were F644.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Pennsylvania surveyors wrote
F644 findings written in Pennsylvania, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
D · No harm, potential for more than minimal, isolatedAugust 28, 2026
Based on review of facility policy, clinical record review and staff interview, it was determined that the PASRR (Preadmission Screening and Resident Review) was not appropriately completed according to the resident assessment and the facility failed to refer residents with diagnosed mental disorder for level II review for four of four residents reviewed (Residents R85, R104, R16, and R59).
Findings include:
Review of the facility policy titled Pre-admission Screening and Resident Review (PASRR) program, states It is the policy of the facility to assure that all residents admitted to the facility receive a Pre-admission Screening and Resident Review, in accordance with State and Federal Regulations. …
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction